Synthesis and purification of the aflatoxin B₁-lysine adduct

References

• Baertschi SW, Raney KD, Stone MP, Harris TM. (1988). Preparation of the 8,9-epoxide of the mycotoxin aflatoxin B1: the ultimate carcinogenic species. J Am Chem Soc 110:7929–31
   Web of Science ®Google Scholar
• Bodanszky M, Bodanszky A. (1994). The practice of peptide synthesis. 2nd ed. Berlin: Springer
   Google Scholar
• Chen JG, Egner PA, Ng D, et al. (2013). Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China. Cancer Prev Res 6:1038–45
   PubMed Web of Science ®Google Scholar
• Gan LS, Skipper PL, Peng XC, et al. (1988). Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1. Carcinogenesis 9:1323–5
   PubMed Web of Science ®Google Scholar
• Garner RC, Martin CN. (1979). Chemical carcinogens and DNA. In: Grover PL, ed. Fungal toxins, aflatoxins and nucleic acids. West Palm Beach: CRC Press, 187–225
   Google Scholar
• Gong YY, Cardwell K, Hounsa A, et al. (2002). Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: cross sectional study. Brit Med J 325:20–1
   PubMed Web of Science ®Google Scholar
• Groopman JD, Egner PA, Schulze KJ, et al. (2014). Aflatoxin exposure during the first 1000 days of life in rural South Asia assessed by aflatoxin B1-lysine albumin biomarkers. Food Chem Toxicol 74:184–9
   PubMed Web of Science ®Google Scholar
• Guengerich FP, Johnson WW. (1999). Kinetics of hydrolysis and reaction of aflatoxin B1 exo-8,9-epoxide and relevance to toxicity and detoxification. Drug Metab Rev 31:141–58
   PubMed Web of Science ®Google Scholar
• Guengerich FP, Arneson KO, Williams KM, et al. (2002). Reaction of aflatoxin B1 oxidation products with lysine. Chem Res Toxicol 15:780–92
   PubMed Web of Science ®Google Scholar
• Hsieh DPH, Atkinson DN. (1991). Bisfuranoid mycotoxins: their genotoxicity and carcinogenicity. Adv Exp Med Biol 283:525–32
   PubMedGoogle Scholar
• International Agency for Research on Cancer (IARC). (1993). WHO IARC monographs on the evaluation of carcinogenic risks to humans. Some naturally carcinogenic risks to humans. Some naturally cyclic aromatic amines and mycotoxins. Aflatoxins 56:245–395
   Google Scholar
• Jager AV, Ramalho FS, Ramalho LNZ, Oliveira CAF. (2011). Biomarkers of aflatoxin exposure and its relationship with the hepatocellular carcinoma. In: Guevara-González, RG, ed. Aflatoxins: biochemistry and molecular biology. Rijeka: Intech – Open Access Publisher, 107–26
   Google Scholar
• Johnson NM, Qian G, Xu L, et al. (2010). Aflatoxin and PAH exposure biomarkers in a U.S. population with a high incidence of hepatocellular carcinoma. Sci Total Environ 408:6027–31
   PubMed Web of Science ®Google Scholar
• Leong YH, Rosma A, Latiff AA, Izzah NA. (2012). Associations of serum aflatoxin B1-lysine adduct level with socio-demographic factors and aflatoxins intake from nuts and related nut products in Malaysia. Int J Hyg Environ Health 215:368–72
   PubMed Web of Science ®Google Scholar
• Magan N, Olsen M, eds. (2004). Mycotoxins in food: detection and control. Abington: Woodhead Publising Limited
   Google Scholar
• Martin CN, Garner RC. (1977). Aflatoxin B-oxide generated by chemical or enzymic oxidation of aflatoxin B1 causes guanine substitution in nucleic acids. Nature 267:863–5
   PubMed Web of Science ®Google Scholar
• Mohd Redzwan S, Rosita J, Mohd Sokhin AM, et al. (2014). Detection of serum AFB1-lysine adduct in Malaysia and its association with liver and kidney functions. Int J Hyg Environ Health 217:443–51
   PubMed Web of Science ®Google Scholar
• Raney KD, Coles B, Guengerich FP, Harris TM. (1992). The endo-8,9-epoxide of aflatoxin B1: a new metabolite. Chem Res Toxicol 5:333–5
   PubMed Web of Science ®Google Scholar
• Sabbioni G. (1990). Chemical and physical properties of the major serum albumin adduct of aflatoxin B1 and their implications for the quantification in biological samples. Chem-Biol Interact 75:1–15
   PubMed Web of Science ®Google Scholar
• Sabbioni G, Skipper PL, Buchi G, Tannenbaum SR. (1987). Isolation and characterization of the major serum albumin adduct formed by aflatoxin B1 in vivo in rats. Carcinogenesis 8:819–24
   PubMed Web of Science ®Google Scholar
• Sass DC, Jager AV, Tonin FG, et al. (2013). Methods for chemical preparation of aflatoxin B1 adducts, AFB1-N7-guanine and AFB1-lysine. J Toxicol Toxin Rev 32:68–74
   Web of Science ®Google Scholar
• Scholl PF, Groopman JD. (2004). Synthesis of 5,5,6,6-D4-l-lysine-aflatoxin Bl for use as a mass spectrometric internal standard. J Labelled Compd Radiopharm 47:807–15
   Web of Science ®Google Scholar
• Scholl PF, Groopman JD. (2008). Long-term stability of human aflatoxin B1 albumin adducts assessed by isotope dilution mass spectrometry and high-performance liquid chromatography-fluorescence. Cancer Epidemiol Biomarkers Prev 17:1436–9
   PubMed Web of Science ®Google Scholar
• Scholl PF, McCoy L, Kensler TW, Groopman JD. (2006). Quantitative analysis and chronic dosimetry of the aflatoxin B1 plasma albumin adduct lys-AFB1 in rats by isotope dilution mass spectrometry. Chem Res Toxicol 19:44–9
   PubMed Web of Science ®Google Scholar
• Scussel VM, Haas P, Gong YY, et al. (2004). Study of aflatoxin exposure in a Brazilian population using an aflatoxin-albumin biomarker. Proceedings of the 11th International IUPAC Symposium on Mycotoxins and Phycotoxins, 197–202; Bethesda, Maryland, USA
   Google Scholar
• Shuaib FMB, Jolly PE, Ehiri JE, et al. (2010). Association between birth outcomes and aflatoxin B1 biomarker blood levels in pregnant women in Kumasi, Ghana. Trop Med Int Health 15:160–7
   PubMed Web of Science ®Google Scholar
• Sujatha N, Suryakala S, Sashidharrao B. (2001). Enzyme immunoassay for aflatoxin B1-lysine adduct and its validation. J AOAC Int 84:1465–74
   PubMedGoogle Scholar
• Sylla A, Diallo MS, Castegnaro J, Wild CP. (1999). Interactions between hepatitis B virus infection and exposure to aflatoxins in the development of hepatocellular carcinoma: a molecular epidemiology approach. Mutat Res 428:87–196
   Google Scholar
• Tang L, Meng T, Xu L, et al. (2008). Modulation of aflatoxin biomarkers in human blood and urine by green tea polyphenols intervention. Carcinogenesis 29:411–17
   PubMed Web of Science ®Google Scholar
• Turner PC, Mendy M, Whittle H, et al. (2000). Hepatitis B infection and aflatoxin biomarker levels in Gambian children. Trop Med Int Health 5:837–41
   PubMed Web of Science ®Google Scholar
• Wild CP, Garner RC, Montesano R, Tursi F. (1986). Aflatoxin B1 binding to plasma albumin and liver DNA upon chronic administration to rats. Carcinogenesis 7:853–8
   PubMed Web of Science ®Google Scholar
• Wild CP, Hudson GJ, Sabbioni G, et al. (1992). Dietary intake of aflatoxins and the level of albumin-bound flatoxin in peripheral blood in The Gambia, West Africa. Cancer Epidemiol Biomarkers Prev 1:229–34
   PubMed Web of Science ®Google Scholar
• Wu H, Santella R. (2012). The role of aflatoxins in hepatocellular carcinoma. Hepat Mon 12:1–9
   Google Scholar
• Xu L, Qian G, Tang L, et al. (2010). Genetic variations of hepatitis B virus and serum aflatoxin-lysine adduct on high risk of hepatocellular carcinoma in Southern Guangxi. China J Hepatol 53:671–6
   PubMedGoogle Scholar